Parnell Pharmaceuticals Holdings Ltd. announced unaudited consolidated earnings results for the six months ended December 31, 2014. For the period, the company reported revenue of AUD 3,662,452 against AUD 2,843,993 a year ago. Loss before income tax was AUD 1,426,080 against AUD 4,416,483 a year ago. Loss for the year was AUD 1,428,522 or AUD 0.11 per basic and diluted share against AUD 4,416,483 or AUD 0.59 per basic and diluted share a year ago.

Increased revenues indicates strong revenue growth in the second half of 2014.

The company also believes that increased revenues in this six months period places on a solid trajectory for strong double-digit revenue growth in 2015 across all operating segments.